Biopsychosocial determinants of opioid use disorder (OUD) and implications for maternal and child health research: A scoping review.


Journal

Journal of opioid management
ISSN: 1551-7489
Titre abrégé: J Opioid Manag
Pays: United States
ID NLM: 101234523

Informations de publication

Date de publication:
Historique:
entrez: 12 3 2019
pubmed: 12 3 2019
medline: 29 5 2019
Statut: ppublish

Résumé

Opioid use disorder (OUD) is on the rise among women of reproductive age in the United States, contributing to a marked increase in the incidence of adverse consequences on maternal and child health (MCH). There is a dearth of literature on the biopsychosocial determinants of OUD in MCH populations and their role in the current opioid epidemic. The aim of this study is to examine the epidemiology of OUD in the United States and develop a biopsychosocial research model of OUD among women of reproductive age. Utilizing a scoping review methodology, a systematic search strategy was implemented using MEDLINE/PubMed, Integrated Library searches, and Google Scholar. Scholarly/peer-reviewed articles published up to July 2017, in English, and restricted to populations in the United States were eligible for inclusion. A qualitative synthesis of the selected studies was performed to summarize study findings. Multiple factors play a role at every level of the biopsychosocial model (BPSM) in OUD-from molecular (genetic, epigenetic), cellular-tissue, organ system, the person (psycho-affective, cognitive, and behavioral), to relation-ship-based (family, peers), community environment, healthcare-related, and policy levels. Important research gaps persist at every level and highlight the need for multiple-level biopsychosocial research to enhance our understanding of the nature, extent, distribution, etiology, and consequences of OUD among women of reproductive age. Our biopsychosocial model of OUD can be used to guide innovative MCH epidemiology research.

Sections du résumé

BACKGROUND BACKGROUND
Opioid use disorder (OUD) is on the rise among women of reproductive age in the United States, contributing to a marked increase in the incidence of adverse consequences on maternal and child health (MCH). There is a dearth of literature on the biopsychosocial determinants of OUD in MCH populations and their role in the current opioid epidemic. The aim of this study is to examine the epidemiology of OUD in the United States and develop a biopsychosocial research model of OUD among women of reproductive age.
METHODS METHODS
Utilizing a scoping review methodology, a systematic search strategy was implemented using MEDLINE/PubMed, Integrated Library searches, and Google Scholar. Scholarly/peer-reviewed articles published up to July 2017, in English, and restricted to populations in the United States were eligible for inclusion. A qualitative synthesis of the selected studies was performed to summarize study findings.
RESULTS RESULTS
Multiple factors play a role at every level of the biopsychosocial model (BPSM) in OUD-from molecular (genetic, epigenetic), cellular-tissue, organ system, the person (psycho-affective, cognitive, and behavioral), to relation-ship-based (family, peers), community environment, healthcare-related, and policy levels.
CONCLUSION CONCLUSIONS
Important research gaps persist at every level and highlight the need for multiple-level biopsychosocial research to enhance our understanding of the nature, extent, distribution, etiology, and consequences of OUD among women of reproductive age. Our biopsychosocial model of OUD can be used to guide innovative MCH epidemiology research.

Identifiants

pubmed: 30855725
pii: jom.2019.0488
doi: 10.5055/jom.2019.0488
pii:
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

77-91

Auteurs

Hamisu M Salihu (HM)

Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas.

Abraham Salinas (A)

Familias Unidas International, Inc., Miami, Florida; Center of Excellence in Maternal and Child Health, Department of Community and Family Health, College of Public Health, University of South Florida, Tampa, Florida.

Imelda Medina (I)

Familias Unidas International, Inc., Miami, Florida.

Janani Krishnaswami (J)

Division of Preventive Medicine, Department of Family and Community Medicine, University of Texas Rio Grande Valley.

Muktar H Aliyu (MH)

Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH